Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean

This publication has 61 references indexed in Scilit:

• Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women
  International Journal of Cancer, 2007
• Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
  The Lancet Infectious Diseases, 2007
• Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18
  Cancer Epidemiology, Biomarkers & Prevention, 2007
• Human Papillomavirus Type 33 Polymorphisms and High‐Grade Squamous Intraepithelial Lesions of the Uterine Cervix
  The Journal of Infectious Diseases, 2006
• Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
  Vaccine, 2006
• Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:
  Sexually Transmitted Diseases, 2003
• Human papillomavirus type‐16 variants in Quechua aboriginals from Argentina
  Journal of Medical Virology, 2003
• Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua
  Sexually Transmitted Infections, 2002
• Absence of Antibody against Human Papillomavirus Type 16 E6 and E7 in Patients with Cervical Cancer Is Independent of Sequence Variations
  The Journal of Infectious Diseases, 2000
• Human Papillomavirus Infection and Cervical Cancer in Latin America
  New England Journal of Medicine, 1989